Page last updated: 2024-09-03

kallidin, des-arg(10)- and dinoprostone

kallidin, des-arg(10)- has been researched along with dinoprostone in 4 studies

Compound Research Comparison

Studies
(kallidin, des-arg(10)-)
Trials
(kallidin, des-arg(10)-)
Recent Studies (post-2010)
(kallidin, des-arg(10)-)
Studies
(dinoprostone)
Trials
(dinoprostone)
Recent Studies (post-2010) (dinoprostone)
8041729,1051,3466,357

Protein Interaction Comparison

ProteinTaxonomykallidin, des-arg(10)- (IC50)dinoprostone (IC50)
Prostaglandin E2 receptor EP1 subtypeHomo sapiens (human)0.0155
Prostaglandin E2 receptor EP4 subtypeHomo sapiens (human)0.0031
Prostaglandin E2 receptor EP4 subtypeRattus norvegicus (Norway rat)0.0021
Prostaglandin E2 receptor EP3 subtypeHomo sapiens (human)0.002
Prostaglandin E2 receptor EP2 subtypeHomo sapiens (human)0.0087
Prostacyclin receptorHomo sapiens (human)0.26
Prostaglandin E2 receptor EP2 subtypeRattus norvegicus (Norway rat)0.0052

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L1
Barnes, PJ; Belvisi, MG; Cirino, G; Mitchell, JA; Saunders, MA; Warner, TD1
Argaman, M; Fleisher-Berkovich, S; Levant, A; Levy, E1
Bellucci, F; Cucchi, P; Lazzeri, M; Meini, S; Santicioli, P; Turini, D1

Other Studies

4 other study(ies) available for kallidin, des-arg(10)- and dinoprostone

ArticleYear
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
    Bioorganic & medicinal chemistry letters, 2013, Mar-15, Volume: 23, Issue:6

    Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship

2013
Mechanisms of prostaglandin E2 release by intact cells expressing cyclooxygenase-2: evidence for a 'two-component' model.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 288, Issue:3

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Arachidonic Acid; Bradykinin; Calcimycin; Cell Line; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Humans; Inflammation; Interleukin-1; Isoenzymes; Kallidin; Membrane Proteins; Phospholipases A; Phospholipases A2; Prostaglandin-Endoperoxide Synthases; Receptors, Bradykinin

1999
Kinins and neuroinflammation: dual effect on prostaglandin synthesis.
    European journal of pharmacology, 2006, Sep-28, Volume: 546, Issue:1-3

    Topics: Animals; Animals, Newborn; Bradykinin; Cells, Cultured; Dinoprostone; Dose-Response Relationship, Drug; Encephalitis; Kallidin; Kinins; Lipopolysaccharides; Neuroglia; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2

2006
Characterization of kinin receptors in human cultured detrusor smooth muscle cells.
    British journal of pharmacology, 2007, Volume: 150, Issue:2

    Topics: Bradykinin; Bradykinin B1 Receptor Antagonists; Cells, Cultured; Dinoprostone; Humans; Inositol Phosphates; Interleukin-1beta; Kallidin; Male; Middle Aged; Muscle, Smooth; Ornithine; Radioligand Assay; Receptor, Bradykinin B1; Sulfonamides; Transforming Growth Factor alpha; Urinary Bladder

2007